Kee Song Bio-Technology Holdings Limited

TPEX:1258 Stock Report

Market Cap: NT$988.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Kee Song Bio-Technology Holdings Past Earnings Performance

Past criteria checks 5/6

Kee Song Bio-Technology Holdings has been growing earnings at an average annual rate of 54.2%, while the Food industry saw earnings growing at 7.4% annually. Revenues have been declining at an average rate of 3.5% per year. Kee Song Bio-Technology Holdings's return on equity is 17.1%, and it has net margins of 4.8%.

Key information

54.24%

Earnings growth rate

54.23%

EPS growth rate

Food Industry Growth7.31%
Revenue growth rate-3.51%
Return on equity17.11%
Net Margin4.81%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Mar 15
Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Nov 30
Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Revenue & Expenses Breakdown

How Kee Song Bio-Technology Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TPEX:1258 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 232,6981303880
31 Dec 222,571953750
30 Sep 222,446613660
30 Jun 222,406993710
31 Mar 222,318763710
31 Dec 212,289743790
30 Sep 212,267123700
30 Jun 212,331483710
31 Mar 212,401573690
31 Dec 202,545-163810
30 Sep 202,721-564010
30 Jun 202,913-904270
31 Mar 202,978-1674560
31 Dec 193,039-1254690
30 Sep 193,005-974770
30 Jun 192,907-2164680
31 Mar 192,940-1704400
31 Dec 182,835-1494160
30 Sep 182,702-1243710
30 Jun 182,66293500
31 Mar 182,553263500
31 Dec 172,481463440
30 Sep 172,467683600
30 Jun 172,4481073570
31 Mar 172,4331223520
31 Dec 162,4361363510
30 Sep 162,3911423300
30 Jun 162,3021413170
31 Mar 162,1211393020
31 Dec 151,8371292870
30 Sep 151,6441342790
30 Jun 151,4161052750
31 Mar 151,304992710
31 Dec 141,309932650
30 Sep 141,289882620
30 Jun 141,278842550
31 Mar 141,264712520
31 Dec 131,259582440
30 Sep 131,278502420
30 Jun 131,299532450
31 Mar 131,323672291
31 Dec 121,343882420
30 Sep 121,338922240
30 Jun 121,329962120

Quality Earnings: 1258 has high quality earnings.

Growing Profit Margin: 1258's current net profit margins (4.8%) are higher than last year (3.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 1258's earnings have grown significantly by 54.2% per year over the past 5 years.

Accelerating Growth: 1258's earnings growth over the past year (70.3%) exceeds its 5-year average (54.2% per year).

Earnings vs Industry: 1258 earnings growth over the past year (70.3%) exceeded the Food industry -4.1%.

Return on Equity

High ROE: 1258's Return on Equity (17.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/10 12:18
End of Day Share Price 2023/05/31 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kee Song Bio-Technology Holdings Limited is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xin LiuCapital Securities Corporation
Titan HorngIBTS Investment Consulting Co., Ltd.
Tsu-ying LinJih Sun Securities Investment Consulting Co., Ltd.